ReP USP - Resultado da busca

Artigo de periodico
Medically ill hospitalized patients for COVID-19 thrombosis extended prophylaxis with rivaroxaban therapy: rationale and design of the MICHELLE trial (2021)
Ramacciotti, Eduardo ; Agati, Leandro Barile; Calderaro, Daniela ; Volpiani, Giuliano Giova; Oliveira, Caroline Candida Carvalho de; Aguiar, Valéria Cristina Resende; Rodrigues, Elizabeth; Sobreira, Marcone Lima ; Joviliano, Edwaldo Edner ; Dusilek, Cesar ; Itinose, Kenji ; Dedivitis, Rogério Aparecido ; Cortina, André Sementilli ; Sanches, Suzanna Maria Viana ; Moraes, Nara Franzin de; Tierno, Paulo Fernando Guimarães Morando Marzocchi ; Oliveira, André Luiz Malavasi Longo de; Tachibana, Adriano ; Chate, Rodrigo Caruso; Santos, Marcus Vinícius Barbosa; Cavalcante, Bruno Bezerra de Menezes ; Moreira, Ricardo Cesar Rocha; Chiann, Chang ; Tafur, Alfonso ; Spyropoulos, Alex C.; Lopes, Renato D
Fonte: American Heart Journal. Unidades: FM, FMRP, IME
Assuntos: COVID-19, TROMBOSE, BIOESTATÍSTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMACCIOTTI, Eduardo et al. Medically ill hospitalized patients for COVID-19 thrombosis extended prophylaxis with rivaroxaban therapy: rationale and design of the MICHELLE trial. American Heart Journal, v. 242, p. 115-122, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2021.08.016. Acesso em: 02 nov. 2025.
APA
Ramacciotti, E., Agati, L. B., Calderaro, D., Volpiani, G. G., Oliveira, C. C. C. de, Aguiar, V. C. R., et al. (2021). Medically ill hospitalized patients for COVID-19 thrombosis extended prophylaxis with rivaroxaban therapy: rationale and design of the MICHELLE trial. American Heart Journal, 242, 115-122. doi:10.1016/j.ahj.2021.08.016
NLM
Ramacciotti E, Agati LB, Calderaro D, Volpiani GG, Oliveira CCC de, Aguiar VCR, Rodrigues E, Sobreira ML, Joviliano EE, Dusilek C, Itinose K, Dedivitis RA, Cortina AS, Sanches SMV, Moraes NF de, Tierno PFGMM, Oliveira ALML de, Tachibana A, Chate RC, Santos MVB, Cavalcante BB de M, Moreira RCR, Chiann C, Tafur A, Spyropoulos AC, Lopes RD. Medically ill hospitalized patients for COVID-19 thrombosis extended prophylaxis with rivaroxaban therapy: rationale and design of the MICHELLE trial [Internet]. American Heart Journal. 2021 ; 242 115-122.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2021.08.016
Vancouver
Ramacciotti E, Agati LB, Calderaro D, Volpiani GG, Oliveira CCC de, Aguiar VCR, Rodrigues E, Sobreira ML, Joviliano EE, Dusilek C, Itinose K, Dedivitis RA, Cortina AS, Sanches SMV, Moraes NF de, Tierno PFGMM, Oliveira ALML de, Tachibana A, Chate RC, Santos MVB, Cavalcante BB de M, Moreira RCR, Chiann C, Tafur A, Spyropoulos AC, Lopes RD. Medically ill hospitalized patients for COVID-19 thrombosis extended prophylaxis with rivaroxaban therapy: rationale and design of the MICHELLE trial [Internet]. American Heart Journal. 2021 ; 242 115-122.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2021.08.016
Artigo de periodico
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial (2020)
Biagioni, Rodrigo Bruno; Lopes, Renato Delascio; Agati, Leandro Barile; Sacilotto, Roberto; Wolosker, Nelson ; Sobreira, Marcone Lima; Soares, Bruno Leonardo de Freitas; Joviliano, Edwaldo Edner ; Bernardi, Walkiria Hueb; Castelli Junior, Valter; Caffaro, Roberto Augusto; Fioranelli, Alexandre; Bellen, Bonno Van; Casella, Ivan Benaduce; Fidelis, Ronald José Ribeiro; Flumignan, Ronald Luiz Gomes; Comerota, Anthony James; Ramacciotti, Eduardo
Fonte: American Heart Journal. Unidades: FM, FMRP
Assuntos: ANGIOPLASTIA, ISQUEMIA, CIRURGIA, PERNA, ESTUDOS MULTICÊNTRICOS, ARTÉRIA POPLÍTEA, COMPLICAÇÕES PÓS-OPERATÓRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIAGIONI, Rodrigo Bruno et al. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. American Heart Journal, v. 227, p. 100-106, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2020.06.010. Acesso em: 02 nov. 2025.
APA
Biagioni, R. B., Lopes, R. D., Agati, L. B., Sacilotto, R., Wolosker, N., Sobreira, M. L., et al. (2020). Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. American Heart Journal, 227, 100-106. doi:10.1016/j.ahj.2020.06.010
NLM
Biagioni RB, Lopes RD, Agati LB, Sacilotto R, Wolosker N, Sobreira ML, Soares BL de F, Joviliano EE, Bernardi WH, Castelli Junior V, Caffaro RA, Fioranelli A, Bellen BV, Casella IB, Fidelis RJR, Flumignan RLG, Comerota AJ, Ramacciotti E. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial [Internet]. American Heart Journal. 2020 ; 227 100-106.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2020.06.010
Vancouver
Biagioni RB, Lopes RD, Agati LB, Sacilotto R, Wolosker N, Sobreira ML, Soares BL de F, Joviliano EE, Bernardi WH, Castelli Junior V, Caffaro RA, Fioranelli A, Bellen BV, Casella IB, Fidelis RJR, Flumignan RLG, Comerota AJ, Ramacciotti E. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial [Internet]. American Heart Journal. 2020 ; 227 100-106.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2020.06.010
Artigo de periodico
An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: rationale and design of the BRIDGE STROKE Trial (2019)
Machline-Carrion, Maria Julia; Santucci, Eliana Vieira; Damiani, Lucas Petri; Bahit, Cecilia; Málaga, Germán; Pontes Neto, Octávio Marques ; Martins, Sheila Cristina Ouriques; Zétola, Viviane de Hiroki Flumignan; Silva, Karina Normilio; Freitas, Gabriel Rodrigues de; Gorgulho, Alessandra; Salles, Antônio de; Silva, Beatriz Gonzales Pacheco da; Santos, Juliana Yamashita; Andrade Jesuíno, Isabella de; Bueno, Priscila Regina Torres; Cavalcanti, Alexandre Biasi; Guimarães, Hélio Penna; Xian, Ying; Bettger, Janet Prvu; Lopes, Renato D.; Peterson, Eric D.; Berwanger, Otávio
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: ISQUEMIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHLINE-CARRION, Maria Julia et al. An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: rationale and design of the BRIDGE STROKE Trial. American Heart Journal, v. 207, p. 49-57, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2018.09.009. Acesso em: 02 nov. 2025.
APA
Machline-Carrion, M. J., Santucci, E. V., Damiani, L. P., Bahit, C., Málaga, G., Pontes Neto, O. M., et al. (2019). An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: rationale and design of the BRIDGE STROKE Trial. American Heart Journal, 207, 49-57. doi:10.1016/j.ahj.2018.09.009
NLM
Machline-Carrion MJ, Santucci EV, Damiani LP, Bahit C, Málaga G, Pontes Neto OM, Martins SCO, Zétola V de HF, Silva KN, Freitas GR de, Gorgulho A, Salles A de, Silva BGP da, Santos JY, Andrade Jesuíno I de, Bueno PRT, Cavalcanti AB, Guimarães HP, Xian Y, Bettger JP, Lopes RD, Peterson ED, Berwanger O. An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: rationale and design of the BRIDGE STROKE Trial [Internet]. American Heart Journal. 2019 ; 207 49-57.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2018.09.009
Vancouver
Machline-Carrion MJ, Santucci EV, Damiani LP, Bahit C, Málaga G, Pontes Neto OM, Martins SCO, Zétola V de HF, Silva KN, Freitas GR de, Gorgulho A, Salles A de, Silva BGP da, Santos JY, Andrade Jesuíno I de, Bueno PRT, Cavalcanti AB, Guimarães HP, Xian Y, Bettger JP, Lopes RD, Peterson ED, Berwanger O. An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: rationale and design of the BRIDGE STROKE Trial [Internet]. American Heart Journal. 2019 ; 207 49-57.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2018.09.009
Artigo de periodico
Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: the BRIDGE-Cardiovascular Prevention trial (2019)
Machline-Carrion, Maria Julia; Soares, Rafael Marques; Damiani, Lucas Petri; Campos, Viviane Bezerra; Sampaio, Bruna; Yamashita, Juliana; Fonseca, Francisco H.; Izar, Maria Cristina; Amodeo, Celso; Pontes Neto, Octávio Marques; Barros, Pedro Gabriel de Melo; Lopes, Renato D.; Brandão da Silva, Nilton; Guimarães, Hélio Penna; Piegas, Leopoldo; Stein, Airton T.; Berwanger, Otavio
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: CORAÇÃO, CARDIOLOGIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHLINE-CARRION, Maria Julia et al. Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: the BRIDGE-Cardiovascular Prevention trial. American Heart Journal, v. 207, p. 40-48, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2018.10.001. Acesso em: 02 nov. 2025.
APA
Machline-Carrion, M. J., Soares, R. M., Damiani, L. P., Campos, V. B., Sampaio, B., Yamashita, J., et al. (2019). Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: the BRIDGE-Cardiovascular Prevention trial. American Heart Journal, 207, 40-48. doi:10.1016/j.ahj.2018.10.001
NLM
Machline-Carrion MJ, Soares RM, Damiani LP, Campos VB, Sampaio B, Yamashita J, Fonseca FH, Izar MC, Amodeo C, Pontes Neto OM, Barros PG de M, Lopes RD, Brandão da Silva N, Guimarães HP, Piegas L, Stein AT, Berwanger O. Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: the BRIDGE-Cardiovascular Prevention trial [Internet]. American Heart Journal. 2019 ; 207 40-48.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2018.10.001
Vancouver
Machline-Carrion MJ, Soares RM, Damiani LP, Campos VB, Sampaio B, Yamashita J, Fonseca FH, Izar MC, Amodeo C, Pontes Neto OM, Barros PG de M, Lopes RD, Brandão da Silva N, Guimarães HP, Piegas L, Stein AT, Berwanger O. Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: the BRIDGE-Cardiovascular Prevention trial [Internet]. American Heart Journal. 2019 ; 207 40-48.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2018.10.001
Artigo de periodico-carta/editorial
Health promotion: a step beyond prevention in cardiology [Editorial] (2018)
Bittencourt, Márcio Sommer
Fonte: American Heart Journal. Unidade: HU
Assuntos: PROMOÇÃO DA SAÚDE, CARDIOLOGIA, MEDICINA PREVENTIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer. Health promotion: a step beyond prevention in cardiology [Editorial]. American Heart Journal. St. Louis: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.ahj.2017.11.003. Acesso em: 02 nov. 2025. , 2018
APA
Bittencourt, M. S. (2018). Health promotion: a step beyond prevention in cardiology [Editorial]. American Heart Journal. St. Louis: Hospital Universitário, Universidade de São Paulo. doi:10.1016/j.ahj.2017.11.003
NLM
Bittencourt MS. Health promotion: a step beyond prevention in cardiology [Editorial] [Internet]. American Heart Journal. 2018 ; 198 178-179.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2017.11.003
Vancouver
Bittencourt MS. Health promotion: a step beyond prevention in cardiology [Editorial] [Internet]. American Heart Journal. 2018 ; 198 178-179.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2017.11.003
Artigo de periodico
Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial (2017)
Berwanger, Otavio; Silva, Pedro G. M. de Barros e; Barbosa, Roberto Ramos; Precoma, Dalton Bertolim; Figueiredo, Estêvão Lanna; Hajjar, Ludhmila Abrahão; Kruel, Cleber Dario Pinto; Alboim, Carolina; Almeida, Adail Paixão; Dracoulakis, Marianna Deway Andrade; Vargas Filho, Hugo; Carmona, Maria José Carvalho; Maia, Lília Nigro; Oliveira Filho, João Bosco de; Saraiva, Jose Francisco Kerr; Soares, Rafael M.; Damiani, Lucas; Paisani, Denise; Kodama, Alessandra A.; Gonzales, Beatriz; Ikeoka, Dimas T.; Devereaux, Philip J.; Lopes, Renato D.
Fonte: American Heart Journal. Unidade: FM
Assuntos: COMPLICAÇÕES PÓS-OPERATÓRIAS, PROCEDIMENTOS CIRÚRGICOS VASCULARES, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERWANGER, Otavio et al. Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial. American Heart Journal, v. 184, p. 88-96, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2016.11.001. Acesso em: 02 nov. 2025.
APA
Berwanger, O., Silva, P. G. M. de B. e, Barbosa, R. R., Precoma, D. B., Figueiredo, E. L., Hajjar, L. A., et al. (2017). Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial. American Heart Journal, 184, 88-96. doi:10.1016/j.ahj.2016.11.001
NLM
Berwanger O, Silva PGM de B e, Barbosa RR, Precoma DB, Figueiredo EL, Hajjar LA, Kruel CDP, Alboim C, Almeida AP, Dracoulakis MDA, Vargas Filho H, Carmona MJC, Maia LN, Oliveira Filho JB de, Saraiva JFK, Soares RM, Damiani L, Paisani D, Kodama AA, Gonzales B, Ikeoka DT, Devereaux PJ, Lopes RD. Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial [Internet]. American Heart Journal. 2017 ; 184 88-96.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2016.11.001
Vancouver
Berwanger O, Silva PGM de B e, Barbosa RR, Precoma DB, Figueiredo EL, Hajjar LA, Kruel CDP, Alboim C, Almeida AP, Dracoulakis MDA, Vargas Filho H, Carmona MJC, Maia LN, Oliveira Filho JB de, Saraiva JFK, Soares RM, Damiani L, Paisani D, Kodama AA, Gonzales B, Ikeoka DT, Devereaux PJ, Lopes RD. Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial [Internet]. American Heart Journal. 2017 ; 184 88-96.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2016.11.001
Artigo de periodico
Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial (2017)
Rosa, Priscila Raupp da; Rohde, Luís Eduardo; Doebber, Madeni; Ribeiro, Antônio L. P.; Prado, Deborah P.; Bertoldi, Eduardo Gehling; Figueiredo Neto, José Albuquerque de; Köhler, Ilmar; Beck-da-Silva, Luís; Danzmann, Luiz Cláudio; Moura, Lídia Zytynski; Rover, Marciane; Simões, Marcus Vinícius; Sant'Anna, Roberto Tofani; Biolo, Andréia
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: BIOMARCADORES, INSUFICIÊNCIA CARDÍACA, PEPTÍDEO NATRIURÉTICO ATRIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSA, Priscila Raupp da et al. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial. American Heart Journal, v. 194, p. 125-131, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2017.08.012. Acesso em: 02 nov. 2025.
APA
Rosa, P. R. da, Rohde, L. E., Doebber, M., Ribeiro, A. L. P., Prado, D. P., Bertoldi, E. G., et al. (2017). Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial. American Heart Journal, 194, 125-131. doi:10.1016/j.ahj.2017.08.012
NLM
Rosa PR da, Rohde LE, Doebber M, Ribeiro ALP, Prado DP, Bertoldi EG, Figueiredo Neto JA de, Köhler I, Beck-da-Silva L, Danzmann LC, Moura LZ, Rover M, Simões MV, Sant'Anna RT, Biolo A. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial [Internet]. American Heart Journal. 2017 ; 194 125-131.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2017.08.012
Vancouver
Rosa PR da, Rohde LE, Doebber M, Ribeiro ALP, Prado DP, Bertoldi EG, Figueiredo Neto JA de, Köhler I, Beck-da-Silva L, Danzmann LC, Moura LZ, Rover M, Simões MV, Sant'Anna RT, Biolo A. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial [Internet]. American Heart Journal. 2017 ; 194 125-131.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2017.08.012
Artigo de periodico
Association between a healthy cardiovascular risk factor profile and coronary artery calcium score: results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) (2016)
Benseñor, Isabela M; Goulart, Alessandra Carvalho ; Santos, Itamar S; Bittencourt, Márcio Sommer; Pereira, Alexandre C; Santos, Raul D; Nasir, Khurram; Blankstein, Ron; Lotufo, Paulo Andrade
Fonte: American Heart Journal. Unidades: FM, HU
Assuntos: DOENÇAS CARDIOVASCULARES, CÁLCIO, FATORES DE RISCO, ESTUDOS LONGITUDINAIS, SAÚDE DO ADULTO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENSEÑOR, Isabela M et al. Association between a healthy cardiovascular risk factor profile and coronary artery calcium score: results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). American Heart Journal, v. 174, p. 51-59, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2015.12.018. Acesso em: 02 nov. 2025.
APA
Benseñor, I. M., Goulart, A. C., Santos, I. S., Bittencourt, M. S., Pereira, A. C., Santos, R. D., et al. (2016). Association between a healthy cardiovascular risk factor profile and coronary artery calcium score: results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). American Heart Journal, 174, 51-59. doi:10.1016/j.ahj.2015.12.018
NLM
Benseñor IM, Goulart AC, Santos IS, Bittencourt MS, Pereira AC, Santos RD, Nasir K, Blankstein R, Lotufo PA. Association between a healthy cardiovascular risk factor profile and coronary artery calcium score: results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) [Internet]. American Heart Journal. 2016 ; 174 51-59.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2015.12.018
Vancouver
Benseñor IM, Goulart AC, Santos IS, Bittencourt MS, Pereira AC, Santos RD, Nasir K, Blankstein R, Lotufo PA. Association between a healthy cardiovascular risk factor profile and coronary artery calcium score: results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) [Internet]. American Heart Journal. 2016 ; 174 51-59.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2015.12.018
Artigo de periodico
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial (2015)
Nicolau, Jose Carlos; Bhatt, Deepak L.; Roe, Matthew T.; Lokhnygina, Yuliya; Neely, Benjamin; Corbalán, Ramón; Leiva-Pons, José L.; Martinez, Felipe; Goodman, Shaun G.; Winters, Kenneth J.; Verheugt, Freek W.A.; Armstrong, Paul W.; White, Harvey D.; Fox, Keith A. A.; Prabhakaran, Dorairaj; Ohman, E. Magnus
Fonte: American Heart Journal. Unidade: FM
Assuntos: SÍNDROME CORONARIANA AGUDA, MEDICAMENTO (ADMINISTRAÇÃO E DOSAGEM), ADMINISTRAÇÃO DOS CUIDADOS AO PACIENTE, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NICOLAU, Jose Carlos et al. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial. American Heart Journal, v. 170, n. 4, p. 683-694, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2015.05.017. Acesso em: 02 nov. 2025.
APA
Nicolau, J. C., Bhatt, D. L., Roe, M. T., Lokhnygina, Y., Neely, B., Corbalán, R., et al. (2015). Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial. American Heart Journal, 170( 4), 683-694. doi:10.1016/j.ahj.2015.05.017
NLM
Nicolau JC, Bhatt DL, Roe MT, Lokhnygina Y, Neely B, Corbalán R, Leiva-Pons JL, Martinez F, Goodman SG, Winters KJ, Verheugt FWA, Armstrong PW, White HD, Fox KAA, Prabhakaran D, Ohman EM. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial [Internet]. American Heart Journal. 2015 ; 170( 4): 683-694.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2015.05.017
Vancouver
Nicolau JC, Bhatt DL, Roe MT, Lokhnygina Y, Neely B, Corbalán R, Leiva-Pons JL, Martinez F, Goodman SG, Winters KJ, Verheugt FWA, Armstrong PW, White HD, Fox KAA, Prabhakaran D, Ohman EM. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial [Internet]. American Heart Journal. 2015 ; 170( 4): 683-694.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2015.05.017
Artigo de periodico
Cardiovascular clinical research in South America (2013)
Nicolau, José C.; Corbalan, Ramon; Diaz, Rafael; Bahit, Cecilia; Armstrong, Paul W.; Granger, Christopher B.; Lopes, Renato D.
Fonte: American Heart Journal. Unidade: FM
Assuntos: PESQUISA BIOMÉDICA, DOENÇAS CARDIOVASCULARES (DIAGNÓSTICO), AMÉRICA DO SUL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NICOLAU, José C. et al. Cardiovascular clinical research in South America. American Heart Journal, v. 165, n. 6, p. 848-853, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2013.02.004. Acesso em: 02 nov. 2025.
APA
Nicolau, J. C., Corbalan, R., Diaz, R., Bahit, C., Armstrong, P. W., Granger, C. B., & Lopes, R. D. (2013). Cardiovascular clinical research in South America. American Heart Journal, 165( 6), 848-853. doi:10.1016/j.ahj.2013.02.004
NLM
Nicolau JC, Corbalan R, Diaz R, Bahit C, Armstrong PW, Granger CB, Lopes RD. Cardiovascular clinical research in South America [Internet]. American Heart Journal. 2013 ; 165( 6): 848-853.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2013.02.004
Vancouver
Nicolau JC, Corbalan R, Diaz R, Bahit C, Armstrong PW, Granger CB, Lopes RD. Cardiovascular clinical research in South America [Internet]. American Heart Journal. 2013 ; 165( 6): 848-853.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2013.02.004
Artigo de periodico
Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial (2013)
Lima, Eduardo Gomes; Hueb, Whady; Garcia, Rosa Maria Rahmi; Pereira, Alexandre Costa; Soares, Paulo Rogerio; Favarato, Desiderio; Garzillo, Cibele Larrosa; Vieira, Ricardo D'Oliveira; Rezende, Paulo Cury; Takiutu, Myrthes; Girardi, Pryscila; Hueb, Alexandre Ciappina; Ramires, José A. F; Kalil Filho, Roberto
Fonte: American Heart Journal. Unidades: FM, MAE
Assuntos: CONTENEDORES, SEGUIMENTOS, CORONARIOPATIA (MORTALIDADE), ANGIOPLASTIA, DIABETES MELLITUS (COMPLICAÇÕES), DOENÇAS CARDIOVASCULARES (CIRURGIA), ARTERIOSCLEROSE (FISIOPATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Eduardo Gomes et al. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. American Heart Journal, v. 166, n. 2, p. 250-257, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2013.04.017. Acesso em: 02 nov. 2025.
APA
Lima, E. G., Hueb, W., Garcia, R. M. R., Pereira, A. C., Soares, P. R., Favarato, D., et al. (2013). Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. American Heart Journal, 166( 2), 250-257. doi:10.1016/j.ahj.2013.04.017
NLM
Lima EG, Hueb W, Garcia RMR, Pereira AC, Soares PR, Favarato D, Garzillo CL, Vieira RD'O, Rezende PC, Takiutu M, Girardi P, Hueb AC, Ramires JAF, Kalil Filho R. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial [Internet]. American Heart Journal. 2013 ; 166( 2): 250-257.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2013.04.017
Vancouver
Lima EG, Hueb W, Garcia RMR, Pereira AC, Soares PR, Favarato D, Garzillo CL, Vieira RD'O, Rezende PC, Takiutu M, Girardi P, Hueb AC, Ramires JAF, Kalil Filho R. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial [Internet]. American Heart Journal. 2013 ; 166( 2): 250-257.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2013.04.017
Artigo de periodico
CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial (2013)
Martinelli, Martino; Rassi Júnior, Anis; Marin Neto , José Antonio; Paola, Angelo Amato Vicenzo de; Berwanger, Otávio; Scanavacca, Maurício Ibraim; Kali, Roberto; Siqueira, Sérgio Freitas de
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: DESFIBRILADORES, MORTE SÚBITA CARDÍACA, DOENÇA DE CHAGAS, CIRURGIA TORÁCICA, PRÓTESES E IMPLANTES, DISPOSITIVO DE ASSISTÊNCIA CIRCULATÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINELLI, Martino et al. CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial. American Heart Journal, v. 166, n. 6, p. 976-982, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2013.08.027. Acesso em: 02 nov. 2025.
APA
Martinelli, M., Rassi Júnior, A., Marin Neto , J. A., Paola, A. A. V. de, Berwanger, O., Scanavacca, M. I., et al. (2013). CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial. American Heart Journal, 166( 6), 976-982. doi:10.1016/j.ahj.2013.08.027
NLM
Martinelli M, Rassi Júnior A, Marin Neto JA, Paola AAV de, Berwanger O, Scanavacca MI, Kali R, Siqueira SF de. CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial [Internet]. American Heart Journal. 2013 ; 166( 6): 976-982.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2013.08.027
Vancouver
Martinelli M, Rassi Júnior A, Marin Neto JA, Paola AAV de, Berwanger O, Scanavacca MI, Kali R, Siqueira SF de. CHronic use of amiodarone aGAinSt implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy study: rationale and design of a randomized clinical trial [Internet]. American Heart Journal. 2013 ; 166( 6): 976-982.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2013.08.027
Artigo de periodico
Optimized duration of clopidogrel therapy following treatment with the endeavor zotarolimus-eluting stent in real-world clinical practice (optimize) trial: rationale and designof a large-scale, randomized, multicenter study (2012)
Feres, Fausto; Costa, Ricardo A.; Bhatt, Deepak L.; Leon, Martin B.; Botelho, Roberto V.; King, Spencer B.; Paula, J. Eduardo T. de; Mangione, José A.; Salvadori Júnior, Décio; Gusmão, Marcos O.; Castello Júnior, Hélio; Nicolela Júnior, Eduardo; Perin, Marco A.; Devito, Fernando S.; Marin Neto, Jose Antonio; Abizaid, Alexandre
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: CORONARIOPATIA, ANTICOAGULANTES (APLICAÇÕES TERAPÊUTICAS), ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERES, Fausto et al. Optimized duration of clopidogrel therapy following treatment with the endeavor zotarolimus-eluting stent in real-world clinical practice (optimize) trial: rationale and designof a large-scale, randomized, multicenter study. American Heart Journal, v. 164, n. 6, p. 810-816, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2012.09.009. Acesso em: 02 nov. 2025.
APA
Feres, F., Costa, R. A., Bhatt, D. L., Leon, M. B., Botelho, R. V., King, S. B., et al. (2012). Optimized duration of clopidogrel therapy following treatment with the endeavor zotarolimus-eluting stent in real-world clinical practice (optimize) trial: rationale and designof a large-scale, randomized, multicenter study. American Heart Journal, 164( 6), 810-816. doi:10.1016/j.ahj.2012.09.009
NLM
Feres F, Costa RA, Bhatt DL, Leon MB, Botelho RV, King SB, Paula JET de, Mangione JA, Salvadori Júnior D, Gusmão MO, Castello Júnior H, Nicolela Júnior E, Perin MA, Devito FS, Marin Neto JA, Abizaid A. Optimized duration of clopidogrel therapy following treatment with the endeavor zotarolimus-eluting stent in real-world clinical practice (optimize) trial: rationale and designof a large-scale, randomized, multicenter study [Internet]. American Heart Journal. 2012 ; 164( 6): 810-816.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2012.09.009
Vancouver
Feres F, Costa RA, Bhatt DL, Leon MB, Botelho RV, King SB, Paula JET de, Mangione JA, Salvadori Júnior D, Gusmão MO, Castello Júnior H, Nicolela Júnior E, Perin MA, Devito FS, Marin Neto JA, Abizaid A. Optimized duration of clopidogrel therapy following treatment with the endeavor zotarolimus-eluting stent in real-world clinical practice (optimize) trial: rationale and designof a large-scale, randomized, multicenter study [Internet]. American Heart Journal. 2012 ; 164( 6): 810-816.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2012.09.009
Artigo de periodico
The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone (2011)
Udelson, James E.; Pearte, Camille A.; Kimmelstiel, Carey D.; Kruk, Mariusz; Kufera, Joseph A.; Forman, Sandra A.; Teresinska, Anna; Bychowiec, Bartosz; Marin Neto , José Antonio; Höchtl, Thomas; Cohen, Eric A.; Caramori, Paulo; Busz-Papiez, Benita; Adlbrecht, Christopher; Sadowski, Zygmunt P.; Ruzyllo, Witold; Kinan, Debra J.; Lamas, Gervasio A.; Hochman, Judith S.
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: MIOCARDIOPATIAS (ESTUDO;TRATAMENTO), INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UDELSON, James E. et al. The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone. American Heart Journal, v. 161, n. 3, p. 611-621, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2010.11.020. Acesso em: 02 nov. 2025.
APA
Udelson, J. E., Pearte, C. A., Kimmelstiel, C. D., Kruk, M., Kufera, J. A., Forman, S. A., et al. (2011). The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone. American Heart Journal, 161( 3), 611-621. doi:10.1016/j.ahj.2010.11.020
NLM
Udelson JE, Pearte CA, Kimmelstiel CD, Kruk M, Kufera JA, Forman SA, Teresinska A, Bychowiec B, Marin Neto JA, Höchtl T, Cohen EA, Caramori P, Busz-Papiez B, Adlbrecht C, Sadowski ZP, Ruzyllo W, Kinan DJ, Lamas GA, Hochman JS. The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone [Internet]. American Heart Journal. 2011 ; 161( 3): 611-621.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2010.11.020
Vancouver
Udelson JE, Pearte CA, Kimmelstiel CD, Kruk M, Kufera JA, Forman SA, Teresinska A, Bychowiec B, Marin Neto JA, Höchtl T, Cohen EA, Caramori P, Busz-Papiez B, Adlbrecht C, Sadowski ZP, Ruzyllo W, Kinan DJ, Lamas GA, Hochman JS. The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone [Internet]. American Heart Journal. 2011 ; 161( 3): 611-621.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2010.11.020
Artigo de periodico
Mutations in the human phospholamban gene in patients with heart failure (2011)
Medeiros, Alessandra; Biagi, Diogo G.; Sobreira, Tiago J. P.; Oliveira, Paulo Sérgio L. de; Negrão, C. E.; Mansur, Alfredo J.; Krieger, José Eduardo; Brum, Patricia Chakur; Pereira , Alexandre C.
Fonte: American Heart Journal. Unidades: EEFE, FM
Assuntos: MUTAÇÃO GENÉTICA, DOENÇAS CARDIOVASCULARES (ENZIMOLOGIA), INSUFICIÊNCIA CARDÍACA (ENZIMOLOGIA), MIOCARDIOPATIA CONGESTIVA (ENZIMOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS, Alessandra et al. Mutations in the human phospholamban gene in patients with heart failure. American Heart Journal, v. 162, n. 6, p. 1088-1095.e1, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2011.07.028. Acesso em: 02 nov. 2025.
APA
Medeiros, A., Biagi, D. G., Sobreira, T. J. P., Oliveira, P. S. L. de, Negrão, C. E., Mansur, A. J., et al. (2011). Mutations in the human phospholamban gene in patients with heart failure. American Heart Journal, 162( 6), 1088-1095.e1. doi:10.1016/j.ahj.2011.07.028
NLM
Medeiros A, Biagi DG, Sobreira TJP, Oliveira PSL de, Negrão CE, Mansur AJ, Krieger JE, Brum PC, Pereira AC. Mutations in the human phospholamban gene in patients with heart failure [Internet]. American Heart Journal. 2011 ; 162( 6): 1088-1095.e1.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2011.07.028
Vancouver
Medeiros A, Biagi DG, Sobreira TJP, Oliveira PSL de, Negrão CE, Mansur AJ, Krieger JE, Brum PC, Pereira AC. Mutations in the human phospholamban gene in patients with heart failure [Internet]. American Heart Journal. 2011 ; 162( 6): 1088-1095.e1.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2011.07.028
Artigo de periodico
Glycemia and prognosis of patients with chronic heart failure-subanalysis of the long-term prospective randomized controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients (REMADHE) trial (2010)
Issa, Victor S; Amaral, Alexandre F; Cruz, Fátima D; Cruz, Fátima D; Ferreira, Silvia M. Ayub; Guimarães, Guilherme Veiga; Chizzola, Paulo R; Souza, Germano E. C; Bocchi, Edimar Alcides
Fonte: American Heart Journal. Unidades: FM, EEFE
Assuntos: GLICEMIA, PROGNÓSTICO, INSUFICIÊNCIA CARDÍACA, DOENÇA CRÔNICA, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISSA, Victor S et al. Glycemia and prognosis of patients with chronic heart failure-subanalysis of the long-term prospective randomized controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients (REMADHE) trial. American Heart Journal, v. 159, n. 1, p. 90-97, 2010Tradução . . Disponível em: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6W9H-4XY3SNN-J-7&_cdi=6683&_user=5674931&_pii=S0002870309008254&_orig=browse&_coverDate=01%2F31%2F2010&_sk=998409998&view=c&wchp=dGLbVzz-zSkWb&md5=8e61383d6d4617c4943594fe8497d17f&ie=/sdarticle.pdf. Acesso em: 02 nov. 2025.
APA
Issa, V. S., Amaral, A. F., Cruz, F. D., Cruz, F. D., Ferreira, S. M. A., Guimarães, G. V., et al. (2010). Glycemia and prognosis of patients with chronic heart failure-subanalysis of the long-term prospective randomized controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients (REMADHE) trial. American Heart Journal, 159( 1), 90-97. Recuperado de http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6W9H-4XY3SNN-J-7&_cdi=6683&_user=5674931&_pii=S0002870309008254&_orig=browse&_coverDate=01%2F31%2F2010&_sk=998409998&view=c&wchp=dGLbVzz-zSkWb&md5=8e61383d6d4617c4943594fe8497d17f&ie=/sdarticle.pdf
NLM
Issa VS, Amaral AF, Cruz FD, Cruz FD, Ferreira SMA, Guimarães GV, Chizzola PR, Souza GEC, Bocchi EA. Glycemia and prognosis of patients with chronic heart failure-subanalysis of the long-term prospective randomized controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients (REMADHE) trial [Internet]. American Heart Journal. 2010 ; 159( 1): 90-97.[citado 2025 nov. 02 ] Available from: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6W9H-4XY3SNN-J-7&_cdi=6683&_user=5674931&_pii=S0002870309008254&_orig=browse&_coverDate=01%2F31%2F2010&_sk=998409998&view=c&wchp=dGLbVzz-zSkWb&md5=8e61383d6d4617c4943594fe8497d17f&ie=/sdarticle.pdf
Vancouver
Issa VS, Amaral AF, Cruz FD, Cruz FD, Ferreira SMA, Guimarães GV, Chizzola PR, Souza GEC, Bocchi EA. Glycemia and prognosis of patients with chronic heart failure-subanalysis of the long-term prospective randomized controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients (REMADHE) trial [Internet]. American Heart Journal. 2010 ; 159( 1): 90-97.[citado 2025 nov. 02 ] Available from: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6W9H-4XY3SNN-J-7&_cdi=6683&_user=5674931&_pii=S0002870309008254&_orig=browse&_coverDate=01%2F31%2F2010&_sk=998409998&view=c&wchp=dGLbVzz-zSkWb&md5=8e61383d6d4617c4943594fe8497d17f&ie=/sdarticle.pdf
Artigo de periodico
The expanded global registry of acute coronary events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes (2009)
Goodman, Shaun G.; Huang, Wel; Yan, Andrew T.; Budaj, Andrej; Kennelly, Brian M.; Gore, Joel M.; Fox, Keith A. A.; Goldberg, Robert J.; Anderson, Frederick A.; Marin Neto, José Antonio; Pazin Filho, Antonio
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: CORONARIOPATIA (TRATAMENTO), MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOODMAN, Shaun G. et al. The expanded global registry of acute coronary events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. American Heart Journal, v. 158, n. 2, p. 193-201.e5, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2009.06.003. Acesso em: 02 nov. 2025.
APA
Goodman, S. G., Huang, W., Yan, A. T., Budaj, A., Kennelly, B. M., Gore, J. M., et al. (2009). The expanded global registry of acute coronary events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. American Heart Journal, 158( 2), 193-201.e5. doi:10.1016/j.ahj.2009.06.003
NLM
Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KAA, Goldberg RJ, Anderson FA, Marin Neto JA, Pazin Filho A. The expanded global registry of acute coronary events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes [Internet]. American Heart Journal. 2009 ; 158( 2): 193-201.e5.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2009.06.003
Vancouver
Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KAA, Goldberg RJ, Anderson FA, Marin Neto JA, Pazin Filho A. The expanded global registry of acute coronary events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes [Internet]. American Heart Journal. 2009 ; 158( 2): 193-201.e5.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2009.06.003
Artigo de periodico
Association of genetic variants with the metabolic syndrome in 20,806 white women: the women's health genome study (2009)
Goulart, Alessandra Carvalho ; Rexrode, Kathryn M; Cheng, Suzanne; Rose, Lynda; Buring, Julie E; Ridker, Paul M; Zee, Robert Y L
Fonte: American Heart Journal. Unidade: HU
Assuntos: CÉLULAS EPITELIAIS (GENÉTICA), SÍNDROME X METABÓLICA (GENÉTICA), POLIMORFISMO, ANGIOPATIAS DIABÉTICAS (GENÉTICA), GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOULART, Alessandra Carvalho et al. Association of genetic variants with the metabolic syndrome in 20,806 white women: the women's health genome study. American Heart Journal, v. 158, n. 2, p. 257-262, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2009.05.015. Acesso em: 02 nov. 2025.
APA
Goulart, A. C., Rexrode, K. M., Cheng, S., Rose, L., Buring, J. E., Ridker, P. M., & Zee, R. Y. L. (2009). Association of genetic variants with the metabolic syndrome in 20,806 white women: the women's health genome study. American Heart Journal, 158( 2), 257-262. doi:10.1016/j.ahj.2009.05.015
NLM
Goulart AC, Rexrode KM, Cheng S, Rose L, Buring JE, Ridker PM, Zee RYL. Association of genetic variants with the metabolic syndrome in 20,806 white women: the women's health genome study [Internet]. American Heart Journal. 2009 ; 158( 2): 257-262.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2009.05.015
Vancouver
Goulart AC, Rexrode KM, Cheng S, Rose L, Buring JE, Ridker PM, Zee RYL. Association of genetic variants with the metabolic syndrome in 20,806 white women: the women's health genome study [Internet]. American Heart Journal. 2009 ; 158( 2): 257-262.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2009.05.015
Artigo de periodico
Heart failure disease management program experience in 4,545 heart failure admissions to a community hospital (2009)
Pazin Filho, Antonio; Peitz, Pamela; Pianta, Thomas; Carson, Kathryn A.; Russell, Stuart D.; Boulware, Leigh Ebony; Coresh, Josef
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: INSUFICIÊNCIA CARDÍACA CONGESTIVA, HOSPITAIS COMUNITÁRIOS, PLANOS E PROGRAMAS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAZIN FILHO, Antonio et al. Heart failure disease management program experience in 4,545 heart failure admissions to a community hospital. American Heart Journal, v. 158, n. 3, p. 459-466, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2009.06.024. Acesso em: 02 nov. 2025.
APA
Pazin Filho, A., Peitz, P., Pianta, T., Carson, K. A., Russell, S. D., Boulware, L. E., & Coresh, J. (2009). Heart failure disease management program experience in 4,545 heart failure admissions to a community hospital. American Heart Journal, 158( 3), 459-466. doi:10.1016/j.ahj.2009.06.024
NLM
Pazin Filho A, Peitz P, Pianta T, Carson KA, Russell SD, Boulware LE, Coresh J. Heart failure disease management program experience in 4,545 heart failure admissions to a community hospital [Internet]. American Heart Journal. 2009 ; 158( 3): 459-466.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2009.06.024
Vancouver
Pazin Filho A, Peitz P, Pianta T, Carson KA, Russell SD, Boulware LE, Coresh J. Heart failure disease management program experience in 4,545 heart failure admissions to a community hospital [Internet]. American Heart Journal. 2009 ; 158( 3): 459-466.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.ahj.2009.06.024
Artigo de periodico
Rationale and design of the sal-Outcommes trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome (2009)
Schwartz, Gregory G.; Olsson, Anders G.; Ballantyne, Christie M.; Barter, Phillip J.; Holme, Ingar M.; Kallend, David; Leiter, Lawrence A.; Leitersdorf, Eran; McMurray, John J. V.; Shah, Prediman K.; Tardif, Jean-Claude; Chaitman, Bernard R.; Maddux, Regina Duttlinger; Mathieson, John; Haddad, Antonio
Fonte: American Heart Journal. Unidade: FMRP
Assuntos: DOENÇAS CARDIOVASCULARES, MORBIDADE, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHWARTZ, Gregory G. et al. Rationale and design of the sal-Outcommes trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. American Heart Journal, v. 158, n. 6, p. 896-901.e3, 2009Tradução . . Acesso em: 02 nov. 2025.
APA
Schwartz, G. G., Olsson, A. G., Ballantyne, C. M., Barter, P. J., Holme, I. M., Kallend, D., et al. (2009). Rationale and design of the sal-Outcommes trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. American Heart Journal, 158( 6), 896-901.e3.
NLM
Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Shah PK, Tardif J-C, Chaitman BR, Maddux RD, Mathieson J, Haddad A. Rationale and design of the sal-Outcommes trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. American Heart Journal. 2009 ; 158( 6): 896-901.e3.[citado 2025 nov. 02 ]
Vancouver
Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Shah PK, Tardif J-C, Chaitman BR, Maddux RD, Mathieson J, Haddad A. Rationale and design of the sal-Outcommes trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. American Heart Journal. 2009 ; 158( 6): 896-901.e3.[citado 2025 nov. 02 ]

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Indexado em

Afiliação dos autores externos não normalizada